The French Society for Pharmacy Oncology's commentary on the article by Iannopollo M.,published in April 2026 and titled “Rethinking centralised oncology pharmacy practice in the era of flat-dose immunotherapy,subcutaneous formulations and visit-administration day separation: A conceptual analysis and reform proposal”
Restricted accessLetterFirst published online 2026
The French Society for Pharmacy Oncology's commentary on the article by Iannopollo M.,published in April 2026 and titled “Rethinking centralised oncology pharmacy practice in the era of flat-dose immunotherapy,subcutaneous formulations and visit-administration day separation: A conceptual analysis and reform proposal”
KohlerDRMontelloMGoldspielBR, et al.ASHP Guidelines on preventing medication errors with antineoplastic agents. Am J Health Syst Pharm 1 sept 2002; 59: 1648–1668.
2.
GoldspielBHoffmanJMGriffithNL, et al.ASHP Guidelines on preventing medication errors with chemotherapy and biotherapy. Am J Health Syst Pharm 15 avr 2015; 72: e6–35.
3.
MichaeliDTMichaeliJCAlbersS,et al.The healthcare workforce shortage of nurses and physicians: practice, theory, evidence, and ways forward. Policy Polit Nurs Pract nov 2024; 25: 216–227.
DrapeauFClaustreGGaimardS,et al.Préparation des traitements anticancéreux injectables au sein d’une unité de pharmacotechnie : quels leviers disponibles pour optimiser et sécuriser la production ? bull cancer (Paris). mars2023; 110: 301–307.
6.
DevysCDesmarisRCormierN. États des lieux de la pharmacotechnie oncologique en France en 2021. Ann Pharm Fr. Juin2024; 82: 618–628.
7.
HalsenGKrämerI. Assessing the risk to health care staff from long-term exposure to anticancer drugs - the case of monoclonal antibodies. J Oncol Pharm Pract2011; 17: 68–80.
8.
RyanMLamNWrightK,et al.Clinical oncology society of Australia position statement: 2022 update to the safe handling of monoclonal antibodies in healthcare settings. Asia Pac J Clin Oncol déc 2023; 19: 723–730.
9.
BatsonSMitchellSALauD, et al.Automated compounding technology and workflow solutions for the preparation of chemotherapy: a systematic review. Eur J Hosp Pharm nov 2020; 27: 330–336.
10.
GeersingTHPourahmadDMLodewijkF, et al.Analysis of production time and capacity for manual and robotic compounding scenarios for parenteral hazardous drugs. Eur J Hosp Pharm2024; 31: 352–357.
RanchonFSlimanoFAyyoubM, et al.The evolving role of Hospital Oncology Pharmacists (HOPs) in assessing therapeutic innovations and managing toxicities in cancer care. Ann Pharm Fr 8 oct 2025. S0003-4509(25)00146-4. doi:10.1016/j.pharma.2025.10.001PubMed PMID: 41072866.
